3X Effect | 9 Servings | Rapid Clarity Anytime
Unlock a sharper state of mind with 3X Focus 3 Count Tablets — a compact yet powerful boost designed to fuel your mental edge. Each tablet contains 30mg of 7-Hydroxy and Mitragynine Pseudoindoxyl, working together to heighten alertness, improve concentration, and sustain mental energy without the crash.
The Blue Raspberry flavor gives your focus session a refreshing kick, making each dose as enjoyable as it is effective. Whether you’re prepping for a long day, tackling deep work, or pushing through a creative block, Focus helps you stay locked in and performing at your best.
3X Relief 3 Count 30MG Blister Features:
-
30mg per tablet of 7-Hydroxy & Mitragynine Pseudoindoxyl
-
9 total servings (3 tablets)
-
3X enhanced effect for noticeable focus and mental drive
-
Refreshing Blue Raspberry flavor
-
Compact, easy-to-carry size for on-the-go clarity
Suggested Use:
- Take one tablet as needed.
- Do not exceed 1 tablet in 24 hours.
Shipping Information
To ensure timely delivery, we offer:
- Orders shipped within 72 hours via UPS.
- Weekend orders shipped on Monday.
- Overnight orders placed after 3 PM PST are shipped the next business day.
Restrictions
It is important to note the following:
- Age Limit: These tablets are not for sale to individuals under 21.
Shipping Limitations:
- States: Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin
- Cities: San Diego, Oceanside (CA), Denver (CO), Sarasota County (FL), Jerseyville (IL)
- ID Verification: Additionally, verification is required for shipments to Florida, Tennessee, Virginia, and West Virginia.
Disclaimer
Please be aware that these products are not intended to diagnose, treat, cure, or prevent any disease or condition. Furthermore, the U.S. FDA has not approved Kratom as a dietary supplement.
Jitter-Free Focus With Occurs Naturally
3X Focus 3CT 30MG Tablets give you clean concentration in a portable pack you can take anywhere. Stay in control and sharp with On7 Focus tablets. Buy now!



There are no reviews yet.